Research Expert: Sarah Overall
  • Published: Mar 2025
  • Pages: 150
  • SKU: IRTNTR72374

  • growing preference for immunotherapy is driving the Pruritus Drugs Market

    Latest News:- Pruritus Drugs Market: Hematologic pruritus is expected to lead the Application segment during 2024-2028

    Technavio analyzes that the Pruritus Drugs Market is expected to grow at a CAGR of 7.1% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 5.9 billion.There are various factors that contribute to the growth of the market. The Pruritus Drugs Market is witnessing a significant shift towards immunotherapies as an increasing number of patients show a preference for these treatments. Immunotherapies, which include monoclonal antibodies and biologics, work by targeting the underlying causes of itching, providing long-term relief and improved patient outcomes. This trend is expected to continue as research and development in this area progresses. The global market for Pruritus Drugs is anticipated to grow at a robust pace, driven by the increasing prevalence of chronic itch conditions and the expanding pipeline of innovative treatments.

    The Dermatologic Hematologic Pruritus market encompasses drugs used to treat itching caused by various hematologic conditions, primarily characterized by deficiencies in iron levels. This type of pruritus is the most prevalent and is often localized to the perianal and vulvar regions. Iron's role in enzymatic activities is significant, and iron deficiency can lead to an increased risk of pruritus. Additionally, this condition may be linked to other hematologic indications, such as glossitis and angular cheilitis, which cause inflammation in the tongue and mouth. These conditions can persist for an extended period, from days to years. Iron deficiency-related pruritus can significantly impact patients' quality of life and necessitates effective treatment solutions. 

    Know which region is leading the market growth by requesting a sample report

    Pruritus Drugs Market Segmentation

     

    • Application
      • Hematologic pruritus
      • Oncological pruritus
      • Renal pruritus
      • Endocrine pruritus
      • Cholestatic pruritus
    • Geography
      • North America
      • Europe
      • Asia
      • Rest of World (ROW)

     

    Top Performing Companies

    As per our research findings, here are some of the key competitors that are leading the industry

    • AbbVie Inc.
    • Almirall SA
    • Astellas Pharma Inc.
    • Bristol Myers Squibb Co.
    • Cara Therapeutics Inc.
    • Cipla Inc.
    • Eisai Co. Ltd.
    • Eli Lilly and Co.
    • GlaxoSmithKline Plc
    • Glenmark Pharmaceuticals Ltd.
    • Ipca Laboratories
    • Lupin Ltd.
    • Merck and Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Roivant Sciences Ltd.
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.

     

    Find out what is trending in the market by accessing the free PDF report

    Research Analysis Overview

    The Pruritus Drugs Market caters to the relief of itchiness associated with various skin conditions and underlying medical issues. Irritants, medications, and underlying diseases like Brachioradial pruritus, Nocturnal pruritus, Pruritus ani, Senile pruritus, Uremic pruritus, Allergies, Eczema, Psoriasis, Diabetes, Dialysis, Dry skin, Inflammation, Skin discoloration, Rash, Papules, Blisters, and Peripheral sensory neurons are common causes. Dermatology specialists diagnose and treat these symptoms through dermatologic interventions, aiming for symptomatic relief and prevention.

    Market Research Overview

    The Pruritus Drugs Market is a significant segment of the global pharmaceuticals industry, encompassing entities involved in the research and development (R&D) or manufacturing of both generic and non-generic medications, as well as veterinary drugs. According to Technavio, the healthcare market size is determined by the consolidated revenue generated by providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Factors driving the expansion of the pharmaceuticals market include the increasing elderly population, with predictions that by 2050, approximately one-quarter of the US population and Europe's population by 2030 will be over 60 years old. Additionally, underlying medical conditions, such as skin irritants, can lead to itchiness and discomfort, necessitating medication for relief. Prevention and proper diagnosis are crucial in managing symptoms and ensuring effective treatment.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

    Reasons to Consider Purchasing Technavio Market Research Report

    • Current Market Insights: Our reports offer valuable information on the latest market intelligence, competitor strategies, trends, industry changes, customer preferences, and forecasted market opportunities to aid in informed business decisions.

    • Extensive Experience: With over 20 years in market research, Technavio is a trusted name, having published more than 21,000 reports across various industries and regions.

    • High ROI Through In-Depth Research: Technavio specializes in tailored market research reports to meet specific business needs, exploring particular markets, product segments, and demographics. We are also recognized for delivering significant returns on investment through our comprehensive data collection at affordable prices.

    Contacts

    Technavio Research
    Jesse Maida
    Media & Marketing Executive
    US: +1 844 364 1100
    UK: +44 203 893 3200
    Email: media@technavio.com
    Website: www.technavio.com/

    Read News Read Less
    Interested in this report?
    Get your sample now!

Safe and Secure SSL Encrypted

Technavio

  • 2500 USD

[5 reports/month/user]

  • 5000 USD

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization).
    Complimentary Customization Included

*For Enterprise license, go to checkout page

Technavio Get the report (PDF) sent to your email within minutes.